This list is based on the watchlists of people on Stock Events who follow EYWN.STU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Show more...
FAQ
What is Biomerieux stock price today?▼
The current price of EYWN.STU is €92.4 EUR — it has increased by +0.87% in the past 24 hours. Watch Biomerieux stock price performance more closely on the chart.
What is Biomerieux stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biomerieux stocks are traded under the ticker EYWN.STU.
Is Biomerieux stock price growing?▼
EYWN.STU stock has fallen by -0% compared to the previous week, the month change is a -2.22% fall, over the last year Biomerieux has showed a -21.45% decrease.
When is the next Biomerieux earnings date?▼
Biomerieux is going to release the next earnings report on July 28, 2026.
How many employees does Biomerieux have?▼
As of April 15, 2026, the company has 14,147 employees.
In which sector is Biomerieux located?▼
Biomerieux operates in the Other sector.
When did Biomerieux complete a stock split?▼
Biomerieux has not had any recent stock splits.
Where is Biomerieux headquartered?▼
Biomerieux is headquartered in Marcy-l'Étoile, France.